| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Axogen, Inc. | Director | Common Stock | 283,498 | $2,177,265 | $7.68 | 04 Jun 2024 | Direct |
| Axogen, Inc. | Director | Stock Option (right to purchase) | 20,436 | $142,030 | $6.95 | 01 Sep 2023 | Direct |
| PDS Biotechnology Corp | Director | Common Stock | 61,213 | $101,614 | $1.66 | 28 Feb 2025 | Direct |
| Axogen, Inc. | Director | Restricted Stock Units | 0 | $0 | $7.68 | 04 Jun 2024 | Direct |
| PDS Biotechnology Corp | Director | Employee Stock Option (Right to Buy) | 22,700 | 11 Jun 2025 | Direct | ||
| PDS Biotechnology Corp | Director | Common Warrant | 15,060 | 28 Feb 2025 | Direct | ||
| ZyVersa Therapeutics, Inc. | Director | Stock Options | 11,066 | 11 Jul 2025 | Direct | ||
| PDS Biotechnology Corp | Director | Employee Stock Option (Right to Buy) | 9,000 | 24 Jun 2024 | Direct | ||
| ZyVersa Therapeutics, Inc. | Director | Stock Options | 132 | 24 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. | 11 Jul 2025 | 1 | $0 | 4 | Director | 15 Jul 2025, 16:22 |
| PDSB | PDS Biotechnology Corp | 11 Jun 2025 | 1 | $0 | 4 | Director | 11 Jun 2025, 18:00 |
| PDSB | PDS Biotechnology Corp | 28 Feb 2025 | 2 | +$25,000 | 4 | Director | 03 Mar 2025, 16:45 |
| PDSB | PDS Biotechnology Corp | 24 Jun 2024 | 1 | $0 | 4 | Director | 25 Jun 2024, 16:05 |
| AXGN | Axogen, Inc. | 04 Jun 2024 | 2 | $0 | 4 | Director | 06 Jun 2024, 16:49 |
| AXGN | Axogen, Inc. | 07 Mar 2024 | 1 | -$225,000 | 4 | Director | 08 Mar 2024, 17:31 |
| AXGN | Axogen, Inc. | 01 Sep 2023 | 2 | $0 | 4 | Director | 07 Sep 2023, 06:28 |
| PDSB | PDS Biotechnology Corp | 14 Jul 2023 | 1 | $0 | 4 | Director | 17 Jul 2023, 17:30 |
| AXGN | Axogen, Inc. | 01 Jun 2023 | 4 | -$365,780 | 4 | Director | 05 Jun 2023, 18:47 |
| ZVSA | ZyVersa Therapeutics, Inc. | 24 May 2023 | 1 | $0 | 4 | Director | 18 Jul 2024, 21:35 |
| AXGN | Axogen, Inc. | 23 May 2023 | 2 | -$68,899 | 4 | Director | 24 May 2023, 16:12 |
| ZVSA | ZyVersa Therapeutics, Inc. | 05 Jan 2023 | 0 | $0 | 3 | Director | 17 Jan 2023, 11:51 |
| AXGN | Axogen, Inc. | 14 Nov 2022 | 1 | -$165,620 | 4 | Director | 16 Nov 2022, 15:05 |
| AXGN | Axogen, Inc. | 08 Nov 2022 | 1 | -$162,500 | 4 | Director | 10 Nov 2022, 15:09 |
| AXGN | Axogen, Inc. | 10 Aug 2022 | 1 | -$86,159 | 4 | Director | 11 Aug 2022, 21:50 |
| AXGN | Axogen, Inc. | 04 Aug 2022 | 2 | -$390,647 | 4 | Director | 08 Aug 2022, 17:49 |
| AXGN | Axogen, Inc. | 25 Jul 2022 | 3 | -$0.96 | 4 | Director | 26 Jul 2022, 20:42 |
| PDSB | PDS Biotechnology Corp | 28 Jun 2022 | 1 | $0 | 4 | Director | 29 Jun 2022, 16:15 |
| AXGN | Axogen, Inc. | 01 Jun 2022 | 4 | $0 | 4 | Director | 03 Jun 2022, 16:06 |
| AXGN | Axogen, Inc. | 17 Jun 2021 | 3 | -$6,376 | 4 | Director | 21 Jun 2021, 16:17 |
| PDSB | PDS Biotechnology Corp | 15 Jun 2021 | 2 | +$49,997 | 4 | Director | 17 Jun 2021, 18:45 |
| AXGN | Axogen, Inc. | 04 Jun 2021 | 2 | $0 | 4 | Director | 08 Jun 2021, 16:25 |
| AXGN | Axogen, Inc. | 01 Jun 2021 | 2 | $0 | 4 | Director | 03 Jun 2021, 17:13 |
| AXGN | Axogen, Inc. | 26 May 2021 | 10 | $0 | 4 | Director | 28 May 2021, 16:05 |